pre-IPO PHARMA

COMPANY OVERVIEW

PTx is an integrated biopharmaceutical company committed to the development and commercialization of therapies that improve the treatment of cancer.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Oncology
  • Oncology

  • WEBSITE

    https://www.partnertx.com/


    CAREER WEBSITE

    https://www.partnertx.com/careers


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Dec 15, 2022

    Partner Therapeutics Announces Publication of a Retrospective Cohort Review of 15 LEUKINE Treated Patients with Pediatric Malignancies and Invasive Fungal Disease Refractory to Antifungal Therapy


    Mar 29, 2022

    Partner Therapeutics Announces Publication of Results from Pre-Clinical Study Evaluating Recombinant Murine GM-CSF in Mouse Models of Down Syndrome and Normal Aging


    Feb 17, 2022

    Partner Therapeutics Announces Contract with U.S. Department of Defense for Advanced Development of Leukine to Treat Sulfur Mustard Gas (HD) Exposure


    Sep 20, 2021

    BARDA and Partner Therapeutics foster a new partnership around their FDA-approved drug, Leukine to improve patient care for sepsis patients


    May 19, 2021

    Partner Therapeutics Announces Publication of Clinical Trial Results of Leukine (sargramostim) in Patients with Parkinson's Disease


    For More Press Releases


    Google Analytics Alternative